Before beginning any exercise program, ensure that you’re both ready and able.

Get clearance from a healthcare professional if necessary.

People of all ages ó kids, teens, young adults, pregnant women, older adults,
and people with special needs ó benefit from weight training (see Chapter 22).
The risks of doing nothing are greater than the risks of injury from exercise ó
even for the frail and elderly. Whether youíre a beginner who wants to get
started safely or youíre already fit and want to improve your performance,
weight training improves your current condition (whatever that is) and helps
you achieve your goals of feeling stronger and better about yourself.
Strong muscles help us move better and avoid pain and injury at all stages of
life. Weight training provides the following benefits:

• Increased strength and endurance
• Improved sleep
• Reduced stress
• Enhanced feelings of confide
• Reduced risk of falls
• Strengthened bones
• Boosted metabolism for mor
• Full, independent living

Because weight training strengthens your muscles and improves your muscu-
lar endurance, youíll naturally have more energy to be more active through-
out the day. When youíre physically tired, youíre able to fall asleep more
easily and enjoy a deeper, better quality of sleep. As youíre more refreshed
and energetic, you feel better and accomplish more, which improves your
mood and confidence level. In this manner, your consistent training stimu-
lates an upward cycle of well-being.
Donít wait. Absorb everything you need to know from this book to get going
with a program that is perfect for you. Keep taking the steps you need to
achieve stronger, more toned muscles for a fuller, more enjoyable and active life.

Rimonabant- a
single drug for weight loss, smoking cessation, dyslipidemia, and metabolic
syndrome sounds almost too good to be true, but two clinical trials
presented at the American College of Cardiology

. The first in a new class of drug, Rimonabant is a cannaboid receptor
1 (CB1) antagonist that appears to be taking meeting attendees by surprise.

“Results of this trial
indicate that physicians may finally have a new tool to treat common,
classic complications that are major risk factors for cardiovascular
disease but that are too often treated in isolation, such as hypertension,
dyslipidemia, and type 2 diabetes,”

“Rimonabant
may be helpful in targeting the cause of those clustering abnormalitiesfor
example, abdominal obesityhopefully improving our ability to better
manage cardiovascular risk in an expanding proportion of our patients.”

“At a time when an estimated
50 million people may be affected by metabolic syndrome, this is good
news,” Dr Sidney Smith (University of North Carolina, Chapel
Hill) told heartwire.

Risk-factor improvement
in Rimonabant-treated patients

End point20-mg rimonabantp (compared with placebo) Weight -15 lb <0.001 Waist circumference -9.1 cm <0.001 HDL +23% <0.001 Triglycerides -15% <0.001 CRP -27% <0.001

A
full 44% of subjects taking rimonabant for one year lost more than 20%
of their body weight, compared with only 16.3% of those taking 5-mg
rimonabant and 10.3% of placebo-treated subjects. The number of patients
with metabolic syndrome at study onset dropped by more than 50% in the
20-mg patients.

A help for those who want to
quit smoking :after 10 weeks of treatment, including a two-week run-in
period when they were allowed to continue to smoke and a final four-week
period when smoking abstinence was assessed, smokers randomized to 20
mg of rimonabant were twice as likely to quit as people randomized to
placebo.

Prolonged smoking abstinence

GroupPlacebo (%)20-mg rimonabant (%) p Trial completers 20.6 36.2 0.002 Intention-to-treat population 16.1 27.6 0.0004

“Rimonabant
may have a distinctive dual effect that could prove to be critical in
helping patients to quit smoking while reducing the likelihood of weight
gain.”

In both studies, side effects
were relatively mild and transient, the most commonly cited being nausea
and dizziness. In a press conference following the late-breaking sessions,
Després likened the nausea symptoms to the feeling of having overeaten.
In addition, Rimonabant had no significant impact on blood
pressure, heart rate, or QT interval. Depression and anxiety measures
were also similar between the rimonabant- and placebo-treated patients.

The rimonabant news seemed
to catch cardiologists and other ACC attendees off-guard, many telling
heartwire that they trully believe that Rimonabant it’s
an amaizing drug with high hopes in treating many diseases.

Most of the people who work
in the field of metabolic syndrome feel that obesity is not going to
be able to be cured with one pill, that there are redundant systems
in the brain for controlling appetite. But if you hit one, you may be
able to do something positive, and it does seem like they’ve hit an
important system.

Cigarette smoking and obesity
are the leading causes of death in the US,” Dr Eric Westman
(Duke Clinical Research Center, Durham, NC) reminded . “These very
encouraging findings suggest that Rimonabant could become
a widely used medical therapy.”

Marc Cluzel, Sanofi’s head of research, said in a round of interviews in London that he continues to believe Acomplia can be a winner.

Acomplia, which was to have been marketed in the United States as Zimulti, was withdrawn from FDA consideration last June after an expert panel unanimously recommended against approval out of concern over depressive and suicidal side-effects,but it’s still possible to be accepted on the biggest market in the world.

Data from a new clinical trial of possible use of Acomplia in slowing progression of coronary artery disease was reported this week along with news that 43.4 percent of patients who got rimonabant in this trial suffered psychiatric side effects such as anxiety and depression.But this is not a problem in this moment because researchers discovered the cause of those side effects.

Acomplia, in addition to promoting weight loss by blocking the body’s CB-1 receptors, may also block a receptor in the brain called TRPV1, possibly explaining why the diet pill produces depression, anxiety and suicidal thoughts in some patients, according to researchers.

This is a great news for people around the world,because many suffer of this disease and they need help.Acomplia also helps patiens who suffer from diabeatis,obesity and also people who want to quit smoking.As the times is running we discover that Rimonabant has many many benefits and I thing that now we are able to say that the side effects are minimum

Cluzel also reiterated that Sanofi intends to resubmit rimonabant to the FDA and regulators worldwide in 2009 for approval as a treatment for type 2 diabetes.

This specialist declared the following: “This is a very interesting diet pill that works in a different way that what we knew untill now. It’s very promising and more than that,because we allready have proves that shows that to us.” Dr. Pi-Sunyear’s reserche found that patiens who were treated with Rimonabant lost weight more then any other diet pills and were able to keep it off for two years. The first in a new class of drugs known as CB-1 receptors, Rimonabant is an appetite suppressant that stops chemical messages of hunger from getting through to the brain. The result is not only weight loss but also better regulation of sugar and fat metabolism.

Another benefit outcome of clinical trials of Acomplia is that the drug also appears to reduce cravings for nicotine. According to a trial study reported by the North American Association for the Study of Obesity (NAASO), smokers who took Rimonabant were twice as likely to quit. Further, there was no weight gain associated with quitting, which is often a concern for smokers, especially if they are already overweight. So,the conclusion is that Rimonabant can be used also as a pill for helping people quit smoking.

In another study, this one a joint effort of NAASO and the American Diabetes Association, 38% of the patiens in a group randomized to receive 20 mg of Rimonabant daily stopped smoking after 10 weeks. The subjects who stopped smoking gained an average of only 0,5 pounds. This was in contrast to the fact that only 16% of subjects in a placebo group stopped smoking after 10 weeks. Those in the placebo group who did stop smoking gained an average of 6 pounds. Althought Rimonabant has not officially been approved for use as a smoking cessation aid, its effects on smoking are quite encouraging.

Besides this two big benefits  Acomplia helps people with other problems and diseases such as diabeatis,cardiovascular risks and the newest one is resistens to alcohol fat building effect in the liver.

Alcoholic fatty liver is a cause for  more serious disease, and alcoholism is a leading cause of liver disease in the U.S. and other countries.

“Clinical trials testing the effectiveness of CB1 receptor blockers in the treatment of both alcoholic and nonalcoholic fatty liver and their more severe sequelae may be warranted,” the researchers concluded.

Click here to go to Acomplia main forum and sign up.

Forum Advantages

- Find accurate information About the new diet pill

- You can ask for help

-Discuss with other customers that have used Acomplia

- Find reliable sources to buy Acomplia and the best price

But should we buy Acomplia? The main reason is its recognition and approval from different medical sources and practitioners that have recommended this particular medication to eliminate obesity.Acomplia is a very safe  drug that provides control on the cholesterol level thereby minimizing the chances of cardiac arrest. Another reason as to why people would buy Acomplia is the fact that during the treatment, it lowers the necessary triglycerides content or bad cholesterol level while positive cholesterol or HDL is increased in the body.

Acomplia is a drug that suppres your appetite because it blocks the receptors of the central nervous system located in the brain that are responsible with the desire of eating. Another reason for purchasing it, is that Acomplia contains glucose that in turn regulates and controls the fat metabolism to operate according to the desired pattern. Many patiens who have purchased Acomplia and used it have confirmed that they no longer have to fight with their appetite and hunger for eating foods. Acomplia being a medication does not replace food; it is only a supplement who helps people loss weight,but if you want to loss weight even more you must  support it with  a balanced diet for achieving the best  results. With the proper combination of physical workouts, proper and healthy diets and Acomplia medication can lead to about 20 percent loss of the overall body weight.

Acomplia continues to be a really good way to lose weight and improve your overall health. This is a sure fire way to lose all that unwanted body fat. As well , as brings society one step closer to curing obesity. Hundreds of people die every year because of diseases that can be directly linked to obesity. You can make a difference. Take the first step and learn how to make a change.Buy Acomplia….

But some experts warned that it may be premature to call Acomplia the next big thing in the weight-loss market.

Still, the findings, which appear in the Feb. 15 issue of the Journal of the American Medical Association, could help position Acomplia as a formidable competitor to weight-loss drugs already on the market, such as Abbott’s Meridia (sibutramine) and Roche’s Xenical (orlistat).

Sanofi filed a new drug application for Acomplia with the Food and Drug Administration last year. The FDA is expected to wrap up its review of the weight-loss product in the next week or so.

The study showed that Acomplia is effective and as effective, if not a little more, than the two other drugs already approved for weight loss: sibutramine and orlistat, the study’s lead author F. Xavier Pi-Sunyer, of St. Luke’s-Roosevelt Hospital Center, told United Press International.

Acomplia Rimonabant is a drug to assist obese people to lose weight and it is approved for sale Europe and UK with prescription from 28th June 2006. Since that time, this drug acomplia rimonabant is called a miracle drug for obesity treatment.

As with most drug treatment , acomplia-rimonabant/Acomplia Rimonabant does not work for everyone. Clinical trials of this drug Acomplia Rimonabant demonstrated that 70% of patients were able to lose at least 5% of their body weight over a 12 month period. Around 39% of patients who took acomplia rimonabant managed to lose at least 10% of their bodyweight over the same period. It was also noted that most of the weight loss occurred within the first nine months of this acomplia rimonabant’s treatment.

This means that from now on any Acomplia sold in the European Union will have a change on the labelling to inform patients and doctors of the positive effect that the drug can have on diabetes. At present the labeling of the Acomplia drug only mentioned that it is to be used with diet and exercise to help obese people lose weight or to help overweight people who have diabetes or other illnesses related to their weight.

Sanofi Aventis are very keen to get Acomplia known as a drug to treat diabetes and not just as a weight loss medication. This is extremely important to them because if the drug is prescribed as a diabetes medication it will be covered by most health insurance policies and this will mean that sales will rise. At present health insurance companies are not keen to reimburse patients for weight loss medication except in extreme circumstances.Early studies into Acomplia’s use to help quit smoking are encouraging, too. They suggest that Acomplia may double your chances of kicking the habit for good, without gaining excess weight (often a problem when people give up smoking).

Studies have reported an average weight loss of 10 per cent of bodyweight – with weight staying off, even up to two years later. Research has also revealed that most of the pounds are shed from the difficult to shift area around the waist.

Acomplia has also been shown to support cardiovascular health, improving cholesterol ratios and lowering triglyceride levels (bloodstream fats), and showing promise as an aid for diabetes and heart conditions.

Being a prescription drug it necessitates prior doctors’ recommendation. This may remind you of the long queues and constant look out for a doctors’ appointment. Forget the age-old way of waiting in queues or running around for a doctor’s appointment. You can now order acomplia through online pharmacies. Online pharmacies are a blessing in disguise for people round the world. Besides, facilitating you with the possibility to order Acomplia online, they offer great online support and many other services that must be taken into account

This diet pill usually is recommended for individuals with a BMI or Body Mass Index 28 or more. BMI or Body Mass Index is a calculated sum of body weight in proportion to your height. The greater your BMI or Body Mass Index, the more possibilities you have of health related concerns.

Acomplia is basically a short-term management for obesity. Optimistic weight loss results are reflected when Acomplia medication is clubbed with regular fitness regime and a balanced diet. The customary Acomplia dosage is 20mg which should be consumed with a glass full of water. Overindulgence in Acomplia medication is not suggested, as it may adversely affect your health. Consume Acomplia as directed by the doctor for effectual weight reduction. Do not chew or crush Acomplia pills as it may modify the template of its chemical composition, enhancing chances of side effects.

Usage of Acomplia may cause some side effects, as a consequence of bodily adjustments to this medication which evades over a passage of time. Incase, these or any other side effects persist over an extended period of time, seek immediate medical help. A few of Acomplia side effects can be enumerated as:

§ Dizziness § Nausea § Insomnia § Headache § Dry mouth

Expectant women and breast-feeding mothers should abstain from intake of Acomplia diet pills . Acomplia is a habit-forming drug and therefore should be taken under proper medical supervision. It is advisable to inform the doctor pertaining to your medical history to avert any medical mishap. Realize your true body shape by ordering Acomplia online.

Rimonabant (Generic Acomplia) is an anorectic anti obesity drug. It is a CB1 cannabinoid receptor antagonist. Rimonabant has been found to stop food craving enough to help people lose weight, and could also help curb other unhealthy urges, such as smoking. This is a non-control weightloss solution that in one study, helped people who were overweight drop an average of 20 pounds, and was found to be very useful for patients who suffer from obesity.

Acomplia is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and
abnormal levels of fat in the blood. Patients with large waist
circumference (102 cm in men and 88 cm in women) will
mostly benefit from taking Acomplia.

H ow does it work?

Acomplia tablets contain the active ingredient rimonabant, which is a type of medicine called a cannabinoid-1 receptor antagonist. It is used to aid weight loss in people who are obese or overweight.

Rimonabant works by blocking receptors called cannabinoid-1 receptors (CB1). These are found in the brain, fat tissue, digestive system, liver and muscles.

The CB1 receptors are part of a system in the body called the endocannabinoid system. This system has only recently been discovered and explored. It is involved in regulating energy balance, sugar and fat metabolism and body weight.

The CB1 receptors found in a particular area of the brain called the mesolimbic system are involved in controlling our intake of highly palatable, sweet or fatty foods. Overactivation of the CB1 receptors is associated with increased appetite, cravings for food and fat build-up.

If you take the diet drug Acomplia, you can keep off lost pounds only if you keep taking it, researchers say.

And those who stay on the drug keep their smaller waist, lower blood-fat levels, and higher good cholesterol levels.

If you don’t cut your calories, Acomplia won’t help you lose weight. But obese and overweight people who do eat less lost an average of 14 pounds if they were able to take Acomplia for one year. That’s 10.5 pounds more than those who ate less and got an inactive placebo pill, reports F. Xavier Pi-Sunyer, MD, professor of medicine at Columbia University and chief of endocrinology at St. Luke’s-Roosevelt Hospital, New York.

“I think it is exciting, because [Acomplia] has a new mechanism of action, and seems as effective [for weight loss] as any drug on the market,” Pi-Sunyer tells WebMD. “[Acomplia] does a reasonable job of modest weight loss.”

The results, first reported in 2004, appear in the Feb. 15 issue of The Journal of the American Medical Association.

The FDA has not yet approved Acomplia, but is expected to act soon. In clinical trials, the drug has helped people lose weight. Obese people seem to have an overactive cannabinoid system. By partially shutting this system down, Acomplia helps people resist the craving for highly palatable food popularly known as ‘the munchies.’